0.1067USD-11.08%Mkt Cap: —P/E: —Last update: 2026-06-01
Ainos, Inc., a dual-platform company, focusing artificial intelligencebased smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model t…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)18.11K USD
Gross Profit102.91K USD
Net Income (TTM)-14.77M USD
Revenue/Share0.0040 USD
Last Price0.1067 USD
Fiscal Year End—
MR Quarter—
Employees41
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.14
EPS (TTM)—
EPS (Forward)—
52W Range
0.050263% of range0.1400
52W High0.1400 USD
52W Low0.0502 USD
Profitability
Gross Margin82.89%
Oper. Margin-1418414.30%
EBITDA Margin0.00%
Profit Margin-11897.04%
ROE-195.32%
ROA-70.77%
Growth
Revenue Growth-99.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.61M USD
CapEx (TTM)34.56K USD
FCF Margin3401.59%
FCF Yield—
Net Debt10.97M USD
Net Debt/EBITDA-1.32
Balance Sheet
Debt/Equity1.45
Current Ratio0.56
Quick Ratio0.45
Book Value/Sh0.9320 USD
Cash/Share0.3860 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float2.14M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta2.31
S&P 52W Chg27.94%
Avg Vol (30d)3.71K
Avg Vol (10d)—
Technical Indicators
RSI (14)66.2
MACD0.0037
MACD Signal0.0009
MACD Hist.+0.0028
BB Upper0.1213 USD
BB Middle0.1039 USD
BB Lower0.0865 USD
BB Width33.43%
ATR (14)0.0092 USD
Vol Ratio (20d)2.15x